• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Time-course of apomorphine in the brain of the immature rat after apomorphine injection.

作者信息

Symes A L, Lal S, Soukes T L

出版信息

Arch Int Pharmacodyn Ther. 1976 Oct;223(2):260-4.

PMID:1033736
Abstract

The time-course of apomorphine in brain was studied in 7-day-old and young adult rats following i.p. injection of 10 mg/kg apomorphine. In the adult animals continuous stereotypes behaviour (SB) commenced within 1-2 min and was no longer present at 75 min. The peak concentration of apomorphine was present at 5 min and then declined exponentially (half-life = 10.5 min); only trace amounts (less than 0.01 mug/g) were present at 90 min. In the immature rat apomorphine induced an initial phase of intermittent locomotion lasting about 10 min after which the rats appeared sedated; 60-80 min after injection intermittent SB emerged and terminated 150-180 min after the apomorphine injection. The peak brain concentration of apomorphine was present at 10 min and then declined exponentially (half-life = 28 min). Significant amounts of apomorphine were still present in brain at 150 min and trace amounts evident at 180 min. The reason for the delayed onset of SB in the immature rat is unclear. The longer half-life is presumably related to incomplete development of enzyme systems metabolizing apomorphine in the immature animal.

摘要

相似文献

1
Time-course of apomorphine in the brain of the immature rat after apomorphine injection.
Arch Int Pharmacodyn Ther. 1976 Oct;223(2):260-4.
2
Effect of amphetamine and apomorphine on brain monoamines and behaviour in the immature and young adult rat.
Arch Int Pharmacodyn Ther. 1975 Dec;218(2):239-51.
3
Behavioral effects and cerebral pharmacokinetics of apomorphine in the rat: dependence upon the route of administration.阿扑吗啡对大鼠的行为影响及脑内药代动力学:取决于给药途径。
Pol J Pharmacol Pharm. 1979 Jul-Aug;31(4):309-17.
4
The expression of locomotor sensitization to apomorphine is dependent on time interval between injection and testing.对阿扑吗啡的运动敏化表达取决于注射与测试之间的时间间隔。
Pharmacol Biochem Behav. 2009 Jan;91(3):278-82. doi: 10.1016/j.pbb.2008.07.003. Epub 2008 Jul 17.
5
Apomorphine: sterotyped behavior and regional distribution in rat brain.阿扑吗啡:大鼠脑中的刻板行为及区域分布
Can J Biochem. 1975 Mar;53(3):308-11. doi: 10.1139/o75-043.
6
Apomorphine and piribedil in rats: biochemical and pharmacologic studies.大鼠体内的阿扑吗啡与吡贝地尔:生化与药理学研究
Adv Neurol. 1975;9:307-26.
7
Methamphetamine-induced behavioural effects and brain concentrations of methamphetamine and its metabolite amphetamine in mice.甲基苯丙胺对小鼠行为的影响以及小鼠体内甲基苯丙胺及其代谢物苯丙胺的脑内浓度
Res Commun Chem Pathol Pharmacol. 1978 Nov;22(2):313-28.
8
Disposition of apomorphine in rat brain areas: relationship to stereotypy.阿扑吗啡在大鼠脑区的分布:与刻板行为的关系。
Eur J Pharmacol. 1986 Nov 19;131(2-3):229-36. doi: 10.1016/0014-2999(86)90576-5.
9
Dopaminergic antagonists: effects of 1,2,3,4-tetrahydroisoquinoline and its N-methyl and N-propyl homologs on apomorphine- and L-dopa-induced behavioral effects in rodents.多巴胺能拮抗剂:1,2,3,4-四氢异喹啉及其N-甲基和N-丙基同系物对阿扑吗啡和左旋多巴诱导的啮齿动物行为效应的影响。
J Pharmacol Exp Ther. 1979 Apr;209(1):79-86.
10
Effects of some antidepressant drugs on apomorphine concentration in the central nervous system of rats and apomorphine-induced stereotypy.
Pol J Pharmacol Pharm. 1985 Jul-Aug;37(4):509-15.

引用本文的文献

1
Dopamine D2 autoreceptors in rats are behaviorally functional at 21 but not 10 days of age.大鼠体内的多巴胺D2自身受体在21日龄时具有行为功能,但在10日龄时则没有。
Psychopharmacology (Berl). 1994 Mar;114(2):262-8. doi: 10.1007/BF02244847.
2
Brain and serum concentrations of dopamine analogues after peripheral administration to rats.大鼠外周给药后多巴胺类似物在脑和血清中的浓度
Naunyn Schmiedebergs Arch Pharmacol. 1984 Jun;326(3):203-9. doi: 10.1007/BF00505319.